Does ROSUVASTATIN Cause Joint effusion? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Joint effusion have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
59
Reports of Joint effusion with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
0
Deaths
37
Hospitalizations
How Dangerous Is Joint effusion From ROSUVASTATIN?
Of the 59 reports, 37 (62.7%) required hospitalization.
Is Joint effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Joint effusion?
ADALIMUMAB (1,367)
METHOTREXATE (917)
ETANERCEPT (826)
TOFACITINIB (520)
LEFLUNOMIDE (407)
TOCILIZUMAB (391)
HYDROXYCHLOROQUINE (380)
INFLIXIMAB (372)
RITUXIMAB (368)
PREDNISONE (357)
Which ROSUVASTATIN Alternatives Have Lower Joint effusion Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN